Mutations in PTCH1 were most prevalent in endometrial cancer (TCGA-UCEC), colon adenocarcinoma (TCGA-COAD) and stomach adenocarcinoma (TCGA-STAD) (Table 1). This evidence concerns the gene PTCH1 and endometrial cancer.